|
|
Article: CVM issues update on compounding of clenbuterol. (Mill Market).(U.S. Food and Drug Administration, report on use of Ventipilum Syrup, containing clenbuterol)(Brief Article)
- Article from:
- Feedstuffs
- Article date:
- January 21, 2002
CopyrightCOPYRIGHT 2002 Miller Publishing Company, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ROCKVILLE, MD. -- A new animal drug application (NADA) for Ventipulmin Syrup, which contains a small amount of clenbuterol, was approved in 1998 as a restricted-use, prescription-only drug for treating horses affected with airway obstruction, according the Food & Drug Administration.
When this approval was granted, FDA said several controls were put in place to ensure the drug would not be misused in food-producing animals.
In a notice issued Jan. 10, FDA emphasized that Ventipulmin is the only clenbuterol drug product approved for use in the U.S. and may only be used in horses not intended for food.
FDA said it has special concern with ...